Terms: = Brain cancer AND BCORL1, ENSG00000085185, 63035, FLJ11362, RP3-510O21_1, B930011H20Rik AND Treatment
23391 results:
1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
2. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
[TBL] [Abstract] [Full Text] [Related]
5. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
[TBL] [Abstract] [Full Text] [Related]
6. Integrated approach of federated learning with transfer learning for classification and diagnosis of brain tumor.
Albalawi E; T R M; Thakur A; Kumar VV; Gupta M; Khan SB; Almusharraf A
BMC Med Imaging; 2024 May; 24(1):110. PubMed ID: 38750436
[TBL] [Abstract] [Full Text] [Related]
7. Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment.
Lu IN; Cheung PF; Heming M; Thomas C; Giglio G; Leo M; Erdemir M; Wirth T; König S; Dambietz CA; Schroeter CB; Nelke C; Siveke JT; Ruck T; Klotz L; Haider C; Höftberger R; Kleinschnitz C; Wiendl H; Hagenacker T; Meyer Zu Horste G
Nat Commun; 2024 May; 15(1):4120. PubMed ID: 38750052
[TBL] [Abstract] [Full Text] [Related]
8. A multi-institutional meningioma MRI dataset for automated multi-sequence image segmentation.
LaBella D; Khanna O; McBurney-Lin S; Mclean R; Nedelec P; Rashid AS; Tahon NH; Altes T; Baid U; Bhalerao R; Dhemesh Y; Floyd S; Godfrey D; Hilal F; Janas A; Kazerooni A; Kent C; Kirkpatrick J; Kofler F; Leu K; Maleki N; Menze B; Pajot M; Reitman ZJ; Rudie JD; Saluja R; Velichko Y; Wang C; Warman PI; Sollmann N; Diffley D; Nandolia KK; Warren DI; Hussain A; Fehringer JP; Bronstein Y; Deptula L; Stein EG; Taherzadeh M; Portela de Oliveira E; Haughey A; Kontzialis M; Saba L; Turner B; Brüßeler MMT; Ansari S; Gkampenis A; Weiss DM; Mansour A; Shawali IH; Yordanov N; Stein JM; Hourani R; Moshebah MY; Abouelatta AM; Rizvi T; Willms K; Martin DC; Okar A; D'Anna G; Taha A; Sharifi Y; Faghani S; Kite D; Pinho M; Haider MA; Alonso-Basanta M; Villanueva-Meyer J; Rauschecker AM; Nada A; Aboian M; Flanders A; Bakas S; Calabrese E
Sci Data; 2024 May; 11(1):496. PubMed ID: 38750041
[TBL] [Abstract] [Full Text] [Related]
9. Zavegepant for Acute treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Suresh V; Bardhan M; Dave T; Shamim MA; Suresh D; Satish P; Dhakal B; Bhonsale A; Roy P; Padhi BK; Monteith T
Clin Neuropharmacol; 2024 May-Jun 01; 47(3):72-81. PubMed ID: 38743600
[TBL] [Abstract] [Full Text] [Related]
10. The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas.
Bobek-Billewicz B; Heinze S; Majchrzak K; Mazgaj P; Hebda A
Folia Neuropathol; 2024; 62(1):13-20. PubMed ID: 38741433
[TBL] [Abstract] [Full Text] [Related]
11. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract] [Full Text] [Related]
12. Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
Petit T; Hajjaji N; Antoine EC; Benderra MA; Gozy M; Foa C; Mouysset JL; Grenier J; Mousseau M; Mailliez A; Saghatchian M; Lachaier E; Desmoulins I; Hennequin A; Maes P; Loirat D; Ricci F; Diéras V; Berton D; Tiong FL; Teixeira L; Dohollou N; Lévy C; Bachelot T; Pierga JY
Cancer Med; 2024 May; 13(9):e7168. PubMed ID: 38733172
[TBL] [Abstract] [Full Text] [Related]
13. MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients.
Affronti ML; Lee J; Molassiotis A; Johnson L; Tinianov S; Clark-Snow R; Scotte F
Support Care Cancer; 2024 May; 32(6):335. PubMed ID: 38727834
[TBL] [Abstract] [Full Text] [Related]
14. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study.
Mordoh J; Schwab E; Bravo AI; Aris M; Barrio MM
Front Immunol; 2024; 15():1354710. PubMed ID: 38726010
[TBL] [Abstract] [Full Text] [Related]
15. Glioma.
Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
[TBL] [Abstract] [Full Text] [Related]
16. Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.
Baugh R; Khalique H; Page E; Lei-Rossmann J; Wan PK; Johanssen T; Ebner D; Ansorge O; Seymour LW
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724464
[TBL] [Abstract] [Full Text] [Related]
17. State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.
Schaff LR; Ioannou M; Geurts M; van den Bent MJ; Mellinghoff IK; Schreck KC
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431450. PubMed ID: 38723228
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative peripheral inflammatory markers are predictors of postoperative central diabetes insipidus in craniopharyngioma patients: a retrospective study.
Wang J; Wang G; Cheng L; Zhu H; Wang J; Ding X; Niu H; Zhao K; Shu K
BMC Cancer; 2024 May; 24(1):572. PubMed ID: 38720306
[TBL] [Abstract] [Full Text] [Related]
19. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.
Everson RG; Hugo W; Sun L; Antonios J; Lee A; Ding L; Bu M; Khattab S; Chavez C; Billingslea-Yoon E; Salazar A; Ellingson BM; Cloughesy TF; Liau LM; Prins RM
Nat Commun; 2024 May; 15(1):3882. PubMed ID: 38719809
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer.
Li L; Xu C; Wang W; Zhang Q
Clin Respir J; 2024 May; 18(5):e13763. PubMed ID: 38717297
[TBL] [Abstract] [Full Text] [Related]
[Next]